IONS
Ionis Pharmaceuticals, Inc.
Stock
$43.54−0.46 (−1.05%)Close Oct 2, 2026
- Selling, general and administrative, 2025
- $394M
- YoY, 2025
- +47.3%
- 5-year CAGR
- +2.1%
- 10-year CAGR
- +26.6%
Selling, general and administrative
Selling, general and administrative by fiscal year
| Period | SG&A | YoY |
|---|---|---|
| 2025 | $394M | +47.3% |
| 2024 | $267M | +15.0% |
| 2023 | $233M | +54.8% |
| 2022 | $150M | −19.3% |
| 2021 | $186M | −47.4% |
| 2020 | $354M | +23.6% |
| 2019 | $287M | +17.2% |
| 2018 | $245M | +125.5% |
| 2017 | $108M | +123.2% |
| 2016 | $49M | +30.8% |
| 2015 | $37M | — |